You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RPRX Sale Disclosure
Hite Christopher · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$1.66M
Hite Christopher EVP & Chairman, Partnering
RPRX
Transaction date
Jun 30, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 2 days later
RPRX daily price context
Close on/before transaction
$56.07
Jun 30, 2026
First close after public filing
$56.92
Jul 6, 2026
30-day return after filing
+0.44%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Ordinary Shares
- Quantity / price
- 29,400 shares @ $56.44
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001814238-26-000011
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$7.35M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Royalty Pharma Plc RPRX | Sale | Jun 30, 2026 | $145.84K |
| Royalty Pharma Plc RPRX Current | Sale | Jun 30, 2026 | $1.66M |
| Royalty Pharma Plc RPRX | Sale | Jun 30, 2026 | $34.25K |
| Royalty Pharma Plc RPRX | Sale | Jun 30, 2026 | $5.51M |